Focus Turns To Biotech Next Week
The week of January 10th is perhaps one of the biggest weeks in the biotechnology industry. Three significant healthcare conferences will take place in San Francisco, headlined by the 29th annual J.P. Morgan Healthcare Conference held at the Westin St. Francis Hotel. The event is attended by the “Who’s Who” of the healthcare industry, with currently over 350 companies registered to attend. Two smaller conferences will also take place next week concurrent with the massive J.P. Morgan conference, the 4th annual OneMed Forum 2011 held at the Sir Francis Drake Hotel and the Biotech Showcase 2011 held at the Parc 55 Wyndham Hotel feature smaller companies from the biotech and medical device industries.
These conferences are an outstanding opportunity for biotech investors to meet face-to-face with both industry leaders and the next great pioneers in the healthcare field. Zacks Small-Cap Research (“Zacks SCR”) analysts that will be in San Francisco to meet with companies and investors are Jason Napodano, CFA, the firm’s Managing Director for Institution Equity Research and Senior Biotechnology Analyst, and Brian Marckx, CFA, the firm’s Senior Medical Device and Technology Analyst. Companies covered by Zacks SCR that are expected to be around these events include: Neurocrine Biosciences (NBIX), Transcept Pharmaceuticals (TSPT), Oxygen Biotherapeutics (OXBT), Pozen Inc. (POZN), Nile Therapeutics (NLTX), Cytomedix (GTF), Acadia Pharmaceuticals (ACAD), Cytori Therapeutics (CYTX), Aastrom Biosciences (ASTM), Zalicus Inc. (ZLCS), Transdel Pharmaceuticals (TDLP), Depomed (DEPO), Redpoint Biosciences (RPBC), Spherix Inc. (SPEX), Datatrack International (DATA), Pressure Biosciences (PBIO), and Chembio Diagnostics (CEMI). Zacks SCR research reports are available on all the above companies prior to the event by emailing [email protected] with the ticker in the subject line. Updated research reports following the event will become available later in the month.
About Zacks Small-Cap Research
Zacks Small-Cap Research coverage specifically looks to focus on small and micro-cap companies that are under-followed or under-valued by Wall Street. Our analysts seek to identify and report on these companies, bringing to investors a unique opportunity to gain insight on small-cap investments, believed to be under-valued and well-positioned for future growth.
Powered by Facebook Comments
Similar Posts: Aastrom Biosciences Inc | ACAD | ACADIA Pharmaceuticals Inc | ASTM | Cytomedix Inc | Cytori Therapeutics Inc | CYTX | DATA | DATATRAK International Inc | DEPO | DepoMed Inc | GTF | NBIX | Neurocrine Biosciences Inc | Nile Therapeutics Inc | NLTX | OXBT | Oxygen Biotherapeutics | PBIO | POZEN Inc | POZN | Pressure BioSciences Inc. | SPEX | Spherix Inc | Transcept Pharmaceuticals Inc | TSPT | Biotechnology | Healthcare
RSS feeds: Aastrom Biosciences Inc | ACAD | ACADIA Pharmaceuticals Inc | ASTM | Cytomedix Inc | Cytori Therapeutics Inc | CYTX | DATA | DATATRAK International Inc | DEPO | DepoMed Inc | GTF | NBIX | Neurocrine Biosciences Inc | Nile Therapeutics Inc | NLTX | OXBT | Oxygen Biotherapeutics | PBIO | POZEN Inc | POZN | Pressure BioSciences Inc. | SPEX | Spherix Inc | Transcept Pharmaceuticals Inc | TSPT | Biotechnology | Healthcare |